1,056
Views
0
CrossRef citations to date
0
Altmetric
Anesthesiology

Dual-neuromodulation strategy in pain management of herpes zoster ophthalmicus: retrospective cohort study and literature review

, , , &
Article: 2288826 | Received 03 Dec 2022, Accepted 23 Nov 2023, Published online: 04 Dec 2023

References

  • Kedar S, Jayagopal LN, Berger JR. Neurological and ophthalmological manifestations of varicella zoster virus. J Neuroophthalmol. 2019;39(2):1–9. doi: 10.1097/WNO.0000000000000721.
  • Liesegang TJ. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology. 2008;115(2 Suppl):S3–S12. doi: 10.1016/j.ophtha.2007.10.009.
  • Feller L, Khammissa RAG, Fourie J, et al. Postherpetic neuralgia and trigeminal neuralgia. Pain Res Treat. 2017;2017:1681765. doi: 10.1155/2017/1681765.
  • Avallone G, Cavallo F, Astrua C, et al. Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experience. J Eur Acad Dermatol Venereol. 2022;36(11):e876–e879. doi: 10.1111/jdv.18386.
  • Rallis KI, Fausto R, Ting DSJ, et al. Manifestation of herpetic eye disease after COVID-19 vaccine: a UK case series. Ocul Immunol Inflamm. 2022;30(5):1136–1141. doi: 10.1080/09273948.2022.2046795.
  • You IC, Ahn M, Cho NC. A case report of herpes zoster ophthalmicus and meningitis after COVID-19 vaccination. J Korean Med Sci. 2022;37(20):e165. doi: 10.3346/jkms.2022.37.e165.
  • Martora F, Fabbrocini G, Picone V. A case of herpes zoster ophthalmicus after third dose of comirnaty (BNT162b2 mRNA) vaccine. Dermatol Ther. 2022;35(5):e15411.
  • Martora F, Villani A, Fabbrocini G, et al. COVID-19 and cutaneous manifestations: a review of the published literature. J Cosmet Dermatol. 2023;22(1):4–10. doi: 10.1111/jocd.15477.
  • Johnson RW, Rice AS. Clinical practice. Postherpetic neuralgia. N Engl J Med. 2014;371(16):1526–1533. doi: 10.1056/NEJMcp1403062.
  • Matthews S, De Maria A, Passamonti M, et al. The economic burden and impact on quality of life of herpes zoster and postherpetic neuralgia in individuals aged 50 years or older in Italy. Open Forum Infect Dis. 2019;6(2):ofz007. doi: 10.1093/ofid/ofz007.
  • Chen N, Li Q, Yang J, et al. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2014;2:CD006866.
  • Pavan-Langston D. Herpes zoster antivirals and pain management. Ophthalmology. 2008;115(2 Suppl):S13–S20. doi: 10.1016/j.ophtha.2007.10.012.
  • Han R, Guo G, Ni Y, et al. Clinical efficacy of short-term peripheral nerve stimulation in management of facial pain associated with herpes zoster ophthalmicus. Front Neurosci. 2020;14:574713. doi: 10.3389/fnins.2020.574713.
  • Ni Y, Yang L, Han R, et al. Implantable peripheral nerve stimulation for trigeminal neuropathic pain: a systematic review and meta-analysis. Neuromodulation. 2021;24(6):983–991. doi: 10.1111/ner.13421.
  • Yang L, Huang Y, Ma J, et al. Clinical outcome of pulsed-radiofrequency combined with transforaminal epidural steroid injection for lumbosacral radicular pain caused by distinct etiology. Front Neurosci. 2021;15:683298. doi: 10.3389/fnins.2021.683298.
  • Manning A, Ortega RG, Moir L, et al. Burst or conventional peripheral nerve field stimulation for treatment of neuropathic facial pain. Neuromodulation. 2019;22(5):645–652. doi: 10.1111/ner.12922.
  • Wan CF, Song T. Short-term peripheral nerve stimulation relieve pain for elder herpes zoster ophthalmicus patients: a retrospective study. Neuromodulation. 2021;24(6):1121–1126. doi: 10.1111/ner.13288.
  • Liu DY, Chen JS, Lin CY, et al. Subcutaneous peripheral nerve stimulation for treatment of acute/subacute herpes zoster-related trigeminal neuralgia: a retrospective research. Clin J Pain. 2021;37(12):867–871. doi: 10.1097/AJP.0000000000000981.
  • Jakobs M, Unterberg A, Treede RD, et al. Subcutaneous trigeminal nerve field stimulation for refractory trigeminal pain: a cohort analysis. Acta Neurochir. 2016;158(9):1767–1774. doi: 10.1007/s00701-016-2881-6.
  • Johnson MD, Burchiel KJ. Peripheral stimulation for treatment of trigeminal postherpetic neuralgia and trigeminal posttraumatic neuropathic pain: a pilot study. Neurosurgery. 2004;55(1):135–142. doi: 10.1227/01.NEU.0000126874.08468.89.
  • Texakalidis P, Tora MS, Anthony CL, et al. Peripheral trigeminal branch stimulation for refractory facial pain: a single-center experience. Clin Neurol Neurosurg. 2020;194:105819. doi: 10.1016/j.clineuro.2020.105819.
  • Klein J, Sandi-Gahun S, Schackert G, et al. Peripheral nerve field stimulation for trigeminal neuralgia, trigeminal neuropathic pain, and persistent idiopathic facial pain. Cephalalgia. 2016;36(5):445–453. doi: 10.1177/0333102415597526.
  • Taub E, Munz M, Tasker RR. Chronic electrical stimulation of the Gasserian ganglion for the relief of pain in a series of 34 patients. J Neurosurg. 1997;86(2):197–202. doi: 10.3171/jns.1997.86.2.0197.
  • Jia Y, Shen Y, Meng L, et al. Efficacy, safety, and predictors of response to pulsed radiofrequency therapy for acute zoster-related trigeminal neuralgia patients: a multicenter retrospective study. Pain Physician. 2022;25(4):E523–E530.
  • Ding Y, Hong T, Li H, et al. Efficacy of CT guided pulsed radiofrequency treatment for trigeminal postherpetic neuralgia. Front Neurosci. 2019;13:708. doi: 10.3389/fnins.2019.00708.
  • Zhang H, Ni H, Liu S, et al. Supraorbital nerve radiofrequency for severe neuralgia caused by herpes zoster ophthalmicus. Pain Res Manag. 2020;2020:3191782–3191787. doi: 10.1155/2020/3191782.
  • Fan X, Ren H, Xu F, et al. Comparison of the efficacy of short-term peripheral nerve stimulation and pulsed radiofrequency for treating herpes zoster ophthalmicus neuralgia. Clin J Pain. 2022;38(11):686–692. doi: 10.1097/AJP.0000000000001074.
  • Liu DY, Chen JS, Fang ZZ, et al. Pulsed radiofrequency of the trigeminal ganglion for treating postherpetic neuralgia of the ophthalmic branch. Pain Res Manag. 2021;2021:9791801. doi: 10.1155/2021/9791801.
  • Wan C, Dong DS, Song T. High-voltage, long-duration pulsed radiofrequency on Gasserian ganglion improves acute/subacute zoster-related trigeminal neuralgia: a randomized, double-blinded, controlled trial. Pain Phys. 2019;22(4):361–368. doi: 10.36076/ppj/2019.22.361.
  • Wan CF, Song T. Comparison of two different pulsed radiofrequency modes for prevention of postherpetic neuralgia in elderly patients with acute/subacute trigeminal herpes zoster. Neuromodulation. 2022;25(8):1364–1371. doi: 10.1111/ner.13457.
  • Li H, Ding Y, Zhu Y, et al. Effective treatment of postherpetic neuralgia at the first branch of the trigeminal nerve by high-voltage pulsed radiofrequency. Front Neurol. 2021;12:746035. doi: 10.3389/fneur.2021.746035.
  • Li M, Hu H, Tong SX, et al. The therapeutic efficacy of pulsed radiofrequency alone versus a dexamethasone and pulsed radiofrequency combination in patients with trigeminal postherpetic neuralgia: a double-blind, randomized controlled trial. Pain Phys. 2022;25(4):E543–E549.
  • Ding Y, Yao P, Li H, et al. CT-guided stellate ganglion pulsed radiofrequency stimulation for facial and upper limb postherpetic neuralgia. Front Neurosci. 2019;13:170. doi: 10.3389/fnins.2019.00170.
  • Zhang JF, Williams JP, Zhao QN, et al. Combined high-voltage pulsed radiofrequency and ozone therapy versus ozone therapy alone in treating postherpetic neuralgia: a retrospective comparison. Med Gas Res. 2023;13(1):15–22. doi: 10.4103/2045-9912.352660.
  • Zhang W, He C. Clinical efficacy of pulsed radiofrequency combined with intravenous lidocaine infusion in the treatment of subacute herpes zoster neuralgia. Pain Res Manag. 2022;2022:5299714–5299753. doi: 10.1155/2022/5299753.
  • McNicol ED, Midbari A, Eisenberg E. Opioids for neuropathic pain. Cochrane Database Syst Rev. 2006;2013(8):CD006146. doi: 10.1002/14651858.CD006146.
  • Wu C-Y, Lin H-C, Chen S-F, et al. Efficacy of pulsed radiofrequency in herpetic neuralgia: a meta-analysis of randomized controlled trials. Clin J Pain. 2020;36(11):887–895. doi: 10.1097/AJP.0000000000000867.
  • Luo G, Zhang Z, Zhu J, et al. Association between the risk of relapse and the type of surgical procedure for herpes zoster-related pain. Pain Phys. 2021;24(8):E1227–E1236.
  • Schmidt GL. The use of spinal cord stimulation/neuromodulation in the management of chronic pain. J Am Acad Orthop Surg. 2019;27(9):e401–e407. doi: 10.5435/JAAOS-D-17-00829.
  • Marchand S. Spinal cord stimulation analgesia: substantiating the mechanisms for neuropathic pain treatment. Pain. 2015;156(3):364–365. doi: 10.1097/01.j.pain.0000000000000089.
  • Kaye AD, Ridgell S, Alpaugh ES, et al. Peripheral nerve stimulation: a review of techniques and clinical efficacy. Pain Ther. 2021;10(2):961–972. doi: 10.1007/s40122-021-00298-1.
  • Van Boxem K, Huntoon M, Van Zundert J, et al. Pulsed radiofrequency: a review of the basic science as applied to the pathophysiology of radicular pain: a call for clinical translation. Reg Anesth Pain Med. 2014;39(2):149–159. doi: 10.1097/AAP.0000000000000063.
  • Berta T, Qadri Y, Tan PH, et al. Targeting dorsal root ganglia and primary sensory neurons for the treatment of chronic pain. Expert Opin Ther Targets. 2017;21(7):695–703. doi: 10.1080/14728222.2017.1328057.
  • Zhou H, Han R, Chen L, et al. Effect of implantable electrical nerve stimulation on cortical dynamics in patients with herpes zoster-related pain: a prospective pilot study. Front Bioeng Biotechnol. 2022;10:862353. doi: 10.3389/fbioe.2022.862353.